Leukocyte adhesion deficiency type I

Last reviewed March 21, 2026

🖨 Print for my doctor Advocacy Hub →

ORPHA:99842OMIM:116920D84.8

Who is this for?

Show terms as

8Treatment centers

Where are you in your journey?

ℹ

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.

Report missing data

Overview

Also known as:

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Leukocyte adhesion deficiency type I.

View clinical trials →

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Leukocyte adhesion deficiency type I at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Leukocyte adhesion deficiency type I community →

Specialists

14 foundView all specialists →

PM

Paul Szabolcs, MD

Pittsburgh, Pennsylvania

Specialist

Rare Disease Specialist

22q11.2 deletion syndrome Adult Krabbe disease Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia+47 more

PI on 7 active trials

Active trials Directions Travel grants

DM

David Deyle, MD

ROCHESTER, MN

Specialist

Congenital disorder of glycosylation Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II

PI on 3 active trials

Active trials Directions Travel grants

DM

Donald B Kohn, MD

NEW HAVEN, CT

Specialist

Albers-Schönberg osteopetrosis Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II+1 more

PI on 3 active trials

Active trials Directions Travel grants

MM

Mary Horowitz, MD, MS

CHICAGO, IL

Specialist

Acute mast cell leukemia Aplastic Anemia Burkitt lymphoma+9 more

PI on 10 active trials

Active trials Directions Travel grants

DD

David Deyle

ROCHESTER, MN

Specialist

Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II

PI on 1 active trial4 Leukocyte adhesion deficiency type I publications

Active trials Directions Travel grants

HM

Harry L Malech, M.D.

Bethesda, Maryland

Specialist

Rare Disease Specialist

Chronic granulomatous disease Leukocyte adhesion deficiency X-linked lymphoproliferative disease

PI on 2 active trials

Active trials Directions Travel grants

CM

Claire Booth, MBBS, PhD, MSc

Specialist

Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II

PI on 2 active trials

Active trials Directions Travel grants

HM

Hisham Abdel-Azim, MD

LOS ANGELES, CA

Specialist

Albers-Schönberg osteopetrosis Aplasia cutis congenita Autosomal recessive severe congenital neutropenia+22 more

PI on 1 active trial

Active trials Directions Travel grants

JM

John T Horan, MD

Specialist

Aplasia cutis congenita Autosomal anomaly syndrome Autosomal recessive severe congenital neutropenia+16 more

PI on 1 active trial

Active trials Directions Travel grants

JP

Julian Sevilla, MD, PhD

Specialist

Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II

PI on 1 active trial

Active trials Directions Travel grants

DM

Donald Kohn, MD

NEW HAVEN, CT

Specialist

Leukocyte adhesion deficiency Leukocyte adhesion deficiency type II

PI on 1 active trial

Active trials Directions Travel grants

BM

Beatriz E Marciano, M.D.

Specialist

Leukocyte adhesion deficiency

PI on 1 active trial

Active trials Directions Travel grants

JP

Julián Sevilla Navarro, MD, PhD

Specialist

Aplastic Anemia Fanconi anemia Leukocyte adhesion deficiency+1 more

PI on 4 active trials

Active trials Directions Travel grants

AY

Abdulgani Orhun yenigün

Specialist

Leukocyte adhesion deficiency

PI on 1 active trial2 Leukocyte adhesion deficiency type I publications

Active trials Directions Travel grants

Treatment Centers

8 centers

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Leukocyte adhesion deficiency type I.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Leukocyte adhesion deficiency type IForum →

No community posts yet. Be the first to share your experience with Leukocyte adhesion deficiency type I.

Start the conversation →

Latest news about Leukocyte adhesion deficiency type I

1 articles

Drug approvalRSSApr 3, 2026

FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

The FDA has approved a new treatment called Kresladi for a rare immune system disorder called Leukocyte Adhesion Deficiency Type I (LAD-I). This treatment works…

See all news about Leukocyte adhesion deficiency type I →

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Leukocyte adhesion deficiency type I

Which specialists treat Leukocyte adhesion deficiency type I?

14 specialists and care centers treating Leukocyte adhesion deficiency type I are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.